Lars Klareskog, Jan Hillert and Anna Fogdell-Hahn from CMM has successfully been granted and included in the IMI consortium. 

March 1st, 2012 the IMI-funded ABIRISK project kicked off officially. The aim of the project is to shed new light on the factors behind the immune response from the so called biological medicines. You can find the the press release from project here.